Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GTx-758 Dose Finding in Prostate Cancer
NCT01393119Phase 2Terminated
- Sponsor
- GTx
- Start
- Aug 2011
- Primary completion
- Dec 2012
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of GTx-758 in prostate cancer (PCa) (4 arms), sponsored by GTx. Primary endpoint: Percentage of Subjects That Reach Castration by Day 28. Started Aug 2011; status: terminated.
02
Drugs
GTx-758
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT01393119.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01393119.